These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
317 related articles for article (PubMed ID: 27794108)
1. FGF21 is a biomarker for mitochondrial translation and mtDNA maintenance disorders. Lehtonen JM; Forsström S; Bottani E; Viscomi C; Baris OR; Isoniemi H; Höckerstedt K; Österlund P; Hurme M; Jylhävä J; Leppä S; Markkula R; Heliö T; Mombelli G; Uusimaa J; Laaksonen R; Laaksovirta H; Auranen M; Zeviani M; Smeitink J; Wiesner RJ; Nakada K; Isohanni P; Suomalainen A Neurology; 2016 Nov; 87(22):2290-2299. PubMed ID: 27794108 [TBL] [Abstract][Full Text] [Related]
2. Diagnostic value of serum biomarkers FGF21 and GDF15 compared to muscle sample in mitochondrial disease. Lehtonen JM; Auranen M; Darin N; Sofou K; Bindoff L; Hikmat O; Uusimaa J; Vieira P; Tulinius M; Lönnqvist T; de Coo IF; Suomalainen A; Isohanni P J Inherit Metab Dis; 2021 Mar; 44(2):469-480. PubMed ID: 32857451 [TBL] [Abstract][Full Text] [Related]
3. Successful Glycemic Control Decreases the Elevated Serum FGF21 Level without Affecting Normal Serum GDF15 Levels in a Patient with Mitochondrial Diabetes. Murakami T; Ueba Y; Shinoto Y; Koga Y; Kaneda D; Hatoko T; Kato T; Yonemitsu S; Muro S; Oki S Tohoku J Exp Med; 2016 Jun; 239(2):89-94. PubMed ID: 27212224 [TBL] [Abstract][Full Text] [Related]
4. Fibroblast growth factor 21 and grow differentiation factor 15 are sensitive biomarkers of mitochondrial diseases due to mitochondrial transfer-RNA mutations and mitochondrial DNA deletions. Formichi P; Cardone N; Taglia I; Cardaioli E; Salvatore S; Gerfo AL; Simoncini C; Montano V; Siciliano G; Mancuso M; Malandrini A; Federico A; Dotti MT Neurol Sci; 2020 Dec; 41(12):3653-3662. PubMed ID: 32504279 [TBL] [Abstract][Full Text] [Related]
5. FGF21 outperforms GDF15 as a diagnostic biomarker of mitochondrial disease in children. Riley LG; Nafisinia M; Menezes MJ; Nambiar R; Williams A; Barnes EH; Selvanathan A; Lichkus K; Bratkovic D; Yaplito-Lee J; Bhattacharya K; Ellaway C; Kava M; Balasubramaniam S; Christodoulou J Mol Genet Metab; 2022 Jan; 135(1):63-71. PubMed ID: 34991945 [TBL] [Abstract][Full Text] [Related]
6. FGF-21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies: a diagnostic study. Suomalainen A; Elo JM; Pietiläinen KH; Hakonen AH; Sevastianova K; Korpela M; Isohanni P; Marjavaara SK; Tyni T; Kiuru-Enari S; Pihko H; Darin N; Õunap K; Kluijtmans LA; Paetau A; Buzkova J; Bindoff LA; Annunen-Rasila J; Uusimaa J; Rissanen A; Yki-Järvinen H; Hirano M; Tulinius M; Smeitink J; Tyynismaa H Lancet Neurol; 2011 Sep; 10(9):806-18. PubMed ID: 21820356 [TBL] [Abstract][Full Text] [Related]
7. A comparison of current serum biomarkers as diagnostic indicators of mitochondrial diseases. Davis RL; Liang C; Sue CM Neurology; 2016 May; 86(21):2010-5. PubMed ID: 27164684 [TBL] [Abstract][Full Text] [Related]
8. Circulating FGF21 and GDF15 as Biomarkers for Screening, Diagnosis, and Severity Assessment of Primary Mitochondrial Disorders in Children. Li Y; Li S; Qiu Y; Zhou M; Chen M; Hu Y; Hong S; Jiang L; Guo Y Front Pediatr; 2022; 10():851534. PubMed ID: 35498801 [TBL] [Abstract][Full Text] [Related]
9. Growth Differentiation Factor 15 Is a Novel Diagnostic Biomarker of Mitochondrial Diseases. Ji X; Zhao L; Ji K; Zhao Y; Li W; Zhang R; Hou Y; Lu J; Yan C Mol Neurobiol; 2017 Dec; 54(10):8110-8116. PubMed ID: 27889897 [TBL] [Abstract][Full Text] [Related]
10. Associations of FGF21 and GDF15 with mitochondrial dysfunction in children living with perinatally-acquired HIV: A cross-sectional evaluation of pediatric AIDS clinical trials group 219/219C. Gojanovich GS; Jacobson DL; Broadwell C; Karalius B; Kirmse B; Geffner ME; Jao J; Van Dyke RB; McFarland EJ; Silio M; Crain M; Gerschenson M; PLoS One; 2021; 16(12):e0261563. PubMed ID: 34972147 [TBL] [Abstract][Full Text] [Related]
11. Fibroblast Growth Factor 21 Drives Dynamics of Local and Systemic Stress Responses in Mitochondrial Myopathy with mtDNA Deletions. Forsström S; Jackson CB; Carroll CJ; Kuronen M; Pirinen E; Pradhan S; Marmyleva A; Auranen M; Kleine IM; Khan NA; Roivainen A; Marjamäki P; Liljenbäck H; Wang L; Battersby BJ; Richter U; Velagapudi V; Nikkanen J; Euro L; Suomalainen A Cell Metab; 2019 Dec; 30(6):1040-1054.e7. PubMed ID: 31523008 [TBL] [Abstract][Full Text] [Related]
12. Expanding and validating the biomarkers for mitochondrial diseases. Maresca A; Del Dotto V; Romagnoli M; La Morgia C; Di Vito L; Capristo M; Valentino ML; Carelli V; J Mol Med (Berl); 2020 Oct; 98(10):1467-1478. PubMed ID: 32851462 [TBL] [Abstract][Full Text] [Related]
13. Elevated FGF 21 in myotonic dystrophy type 1 and mitochondrial diseases. Lovadi E; Csereklyei M; Merkli H; FüLöp K; Sebők Á; Karcagi V; Komoly S; Pál E Muscle Nerve; 2017 Apr; 55(4):564-569. PubMed ID: 27489983 [TBL] [Abstract][Full Text] [Related]
14. Protein biomarkers GDF15 and FGF21 to differentiate mitochondrial hepatopathies from other pediatric liver diseases. Van Hove JLK; Friederich MW; Strode DK; Van Hove RA; Miller KR; Sharma R; Shah H; Estrella J; Gabel L; Horslen S; Kohli R; Lovell MA; Miethke AG; Molleston JP; Romero R; Squires JE; Alonso EM; Guthery SL; Kamath BM; Loomes KM; Rosenthal P; Mysore KR; Cavallo LA; Valentino PL; Magee JC; Sundaram SS; Sokol RJ; Hepatol Commun; 2024 Jan; 8(1):. PubMed ID: 38180987 [TBL] [Abstract][Full Text] [Related]
15. FGF21 in ataxia patients with spinocerebellar atrophy and mitochondrial disease. Su SL; Wang WF; Wu SL; Wu HM; Chang JC; Huang CS; Cheng WL; Soong BW; Lee YC; Li JY; Kuo SJ; Chen M; Huang CN; Liu CS Clin Chim Acta; 2012 Dec; 414():225-7. PubMed ID: 23031666 [TBL] [Abstract][Full Text] [Related]
16. GDF-15 Is Elevated in Children with Mitochondrial Diseases and Is Induced by Mitochondrial Dysfunction. Montero R; Yubero D; Villarroya J; Henares D; Jou C; Rodríguez MA; Ramos F; Nascimento A; Ortez CI; Campistol J; Perez-Dueñas B; O'Callaghan M; Pineda M; Garcia-Cazorla A; Oferil JC; Montoya J; Ruiz-Pesini E; Emperador S; Meznaric M; Campderros L; Kalko SG; Villarroya F; Artuch R; Jimenez-Mallebrera C PLoS One; 2016; 11(2):e0148709. PubMed ID: 26867126 [TBL] [Abstract][Full Text] [Related]
17. Serum FGF21 levels in adult m.3243A>G carriers: clinical implications. Koene S; de Laat P; van Tienoven DH; Vriens D; Brandt AM; Sweep FC; Rodenburg RJ; Donders AR; Janssen MC; Smeitink JA Neurology; 2014 Jul; 83(2):125-33. PubMed ID: 24907231 [TBL] [Abstract][Full Text] [Related]
18. The fibroblast growth factor 21 concentration in children with mitochondrial disease does not depend on the disease stage, but rather on the disease genotype. Wesół-Kucharska D; Rokicki D; Greczan M; Kaczor M; Czekuć-Kryśkiewicz E; Piekutowska-Abramczuk D; Halat-Wolska P; Ciara E; Jaworski M; Jezela-Stanek A Pediatr Endocrinol Diabetes Metab; 2022; 28(2):141-151. PubMed ID: 35620925 [TBL] [Abstract][Full Text] [Related]